Bruce Robinson

45.5k citations

176 papers · 9.7k indexed · 3 hit papers · h-index 49

Impact in

Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research

Papers in

Immunology 73
- Immunotherapy and Immune Responses 59
- Immune Cell Function and Interaction 32
Pulmonary and Respiratory Medicine 85
- Occupational and environmental lung diseases 65
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 33
- Pleural and Pulmonary Diseases 27

Co-authors: Richard Lake Anna K. Nowak Arthur W. Musk Ronald G. Crystal Jenette Creaney Amanda L. Marzo Bernadette Scott Theodore L. McLemore
Journals: The Journal of Immunology (9 papers)Thorax (9 papers)Immunology and Cell Biology (7 papers)OncoImmunology (6 papers)Cancer Immunology Immunotherapy (6 papers)
Partner nations: Australia United States Canada

In The Last Decade

Bruce Robinson

170 papers receiving 9.4k citations

Hit Papers

align trajectories log scale

Malignant mesothelioma 2005 · 533 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2005 The Lancet
2005 Nature reviews. Cancer
1985 Journal of Clinical Investigation

Peers

Countries citing papers authored by Bruce Robinson

Since Specialization

Citations

This map shows the geographic impact of Bruce Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Robinson more than expected).

Fields of papers citing papers by Bruce Robinson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Robinson. The network helps show where Bruce Robinson may publish in the future.

Co-authors

The 25 scholars most cited alongside Bruce Robinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bruce Robinson Line = papers co-authored together Bruce Robinson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19 Vaccines ·Peter J. Richardson, Bruce Robinson, Daniel P. Smith, Justin Stebbing	2022	20
2	A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancers Expert Review of Anticancer Therapy ·Alistair Cook, Alison M. McDonnell, Michael Millward, Jenette Creaney, Arman Hasani, Michelle McMullen, Tarek Meniawy, Bruce Robinson, Richard Lake, Anna K. Nowak	2021	0
3	Local effector failure in mesothelioma is not mediated by CD4⁺CD25⁺T-regulator cells European Respiratory Journal ·Connie Jackaman, Ma'lsagov AKh, Andrew M. Lew, Yifan Zhan, Bruce Robinson, Delia J. Nelson	2009	23
4	Locally Administered TLR7 Agonists Drive Systemic Antitumor Immune Responses That Are Enhanced by Anti-CD40 Immunotherapy The Journal of Immunology ·D. Bertsche, Robbert van der Most, Amy Prosser, Chidera Ekpo, Michaël G. Tovey, Mark J. Smyth, Bruce Robinson, Andrew Currie	2009	77
5	Dual Control of Antitumor CD8 T Cells through the Programmed Death-1/Programmed Death-Ligand 1 Pathway and Immunosuppressive CD4 T Cells: Regulation and Counterregulation The Journal of Immunology ·Andrew Currie, Amy Prosser, Alison M. McDonnell, 武四郎安田, Bruce Robinson, Gordon J. Freeman, Robbert van der Most	2009	48
6	Mesothelin-related predictive and prognostic factors in malignant mesothelioma: A nested case–control study Lung Cancer ·Oluf Dimitri Røe, Jenette Creaney, Steinar Lundgren, Erik G. Larsson, Johannes E. Jäntti, Paolo Boffetta, Tom Ivar Lund Nilsen, Bruce Robinson, Kristina Kjærheim	2008	45
7	Current chemotherapeutic treatment of malignant pleural mesothelioma Expert Opinion on Pharmacotherapy ·Anna K. Nowak, Michael Byrne, Michael Millward, John M. Alvarez, Bruce Robinson	2004	5
8	IL-2 Intratumoral Immunotherapy Enhances CD8+ T Cells That Mediate Destruction of Tumor Cells and Tumor-Associated Vasculature: A Novel Mechanism for IL-2 The Journal of Immunology ·Connie Jackaman, Christine Bundell, Beverley F. Kinnear, M.R. Shaneyfeft, Pierre Filion, Rubinstein Hr, Bruce Robinson, Delia J. Nelson	2003	176
9	Induction of Tumor Cell Apoptosis In Vivo Increases Tumor Antigen Cross-Presentation, Cross-Priming Rather than Cross-Tolerizing Host Tumor-Specific CD8 T Cells The Journal of Immunology ·Anna K. Nowak, Richard Lake, Amanda L. Marzo, Bernadette Scott, William R. Heath, Edward J. Collins, Jeffrey A. Frelinger, Bruce Robinson	2003	361
10	Tumor Progression Despite Efficient Tumor Antigen Cross-Presentation and Effective “Arming” of Tumor Antigen-Specific CTL The Journal of Immunology ·Delia J. Nelson, Sutapa Mukherjee, Christine Bundell, Scott Fisher, Rubinstein Hr, Bruce Robinson	2001	59
11	Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis Respiratory Research ·Cleo Robinson, Marinella Callow, Mahdi Ghasemi Amir, Bruce Robinson, Richard Lake	2001	7
12	In Vivo Cross-Presentation of a Soluble Protein Antigen: Kinetics, Distribution, and Generation of Effector CTL Recognizing Dominant and Subdominant Epitopes The Journal of Immunology ·Delia J. Nelson, Christine Bundell, Bruce Robinson	2000	59
13	Expression and immune recognition of stress proteins in sarcoidosis and other chronic interstitial lung diseases Immunology and Cell Biology ·Janelle Staton, C. S�nchez, Bart J. Currie, David Fitzpatrick, Robyn Himbeck, D. H. Jung, A.Bellini Abellini, Bruce Robinson, Helle Bielefeldt‐Ohmann	1995	11
14	Functional Analysis of Human Bronchial Mucosal T Cells Extracted with Interleukin-2 American Journal of Respiratory and Critical Care Medicine ·John W. Upham, Christine McMenamin, M A Schon-Hegrad, Bruce Robinson, Patrick G. Holt	1994	16
15	The role of platelet derived growth factor in the growth of human malignant mesothelioma European Respiratory Review ·Е. В. Гурина, T.I. Christmas, Steven E. Mutsaers, Luisa Manning, Timothy Davis, Bruce Robinson	1993	9
16	Constitutive and inducible HLA antigen expression in malignant mesothelioma European Respiratory Review ·Е. В. Гурина, T.I. Christmas, Linda Shapiro Manning, Timothy Davis, Bruce Robinson	1993	2
17	Platelet-derived growth factor as an autocrine factor in murine malignant mesothelioma European Respiratory Review ·Е. В. Гурина, T.I. Christmas, Steven E. Mutsaers, Luisa Manning, Timothy Davis, Bruce Robinson	1993	12
18	The scientific basis for the immunotherapy of human malignant mesothelioma European Respiratory Review ·Bruce Robinson, Linda S. Manning, O. Oveckova, T.I. Christmas, A W Musk, Mark R. Davis, Helle Bielefeldt‐Ohmann, John W. Upham, M.J. Garlepp	1993	10
19	Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer Surgical Oncology ·Jan Polster, Bruce Robinson, Noel F. Quenville, Richard J. Finley, Noelle Davis	1992	69
20	Intra-uterine healing of fetal rat cheek wounds. PubMed ·Bruce Robinson, Alastair N. Goss	1981	35

About Bruce Robinson

Bruce Robinson is a scholar working on Immunology, Pulmonary and Respiratory Medicine, Biotechnology, Oncology and Virology, having authored 176 papers that have together received 9.7k indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (65 papers), Immunotherapy and Immune Responses (59 papers), Cancer Immunotherapy and Biomarkers (38 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (33 papers), Immune Cell Function and Interaction (32 papers), Pleural and Pulmonary Diseases (27 papers), Cancer Research and Treatments (22 papers) and CAR-T cell therapy research (20 papers). The work is most often cited by research in Immunology (3.7k citations), Oncology (3.4k citations), Pulmonary and Respiratory Medicine (4.0k citations), Biotechnology (708 citations) and Immunology and Allergy (226 citations). Bruce Robinson has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Richard Lake, Anna K. Nowak, Arthur W. Musk, Ronald G. Crystal, Jenette Creaney, Amanda L. Marzo, Bernadette Scott, Theodore L. McLemore, Delia J. Nelson and W. Joost Lesterhuis. Their work appears in journals such as The Journal of Immunology, Thorax, Immunology and Cell Biology, OncoImmunology and Cancer Immunology Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact